Skip to main content
Log in

5-(thien-2-yl) uracil analogs: 5-(5-methylthien-2-yl)-2′-deoxyuridine, 5-(5-thien-2-yl)-2′-deoxyuridine, and 5-(5-bromothien-2-yl)-2′-deoxyuridine

  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

Crystal structures of 5-(5-methylthien-2-yl)-2′-deoxyuridine (I), 5-(5-thien-2-yl)-2′-deoxyuridine (II) and 5-(5-bromothien-2-yl)-2′-deoxyuridine (III) have been obtained from data collected on a four-circle Enraf-Nonius diffractometer (CAD-4 system). Space group, unit/cell parameters and finalR indices are:I, monoclinic,P21,a=9.105(2),b=20.819(2),c=7.932(2) Å, β=98.79(2)°,R=5.7%;II, monoclinic,P21,a=8.720(4),b=20.793(4),c=7.884(4) Å, β=95.06(2)°,R=5.8%;III, monoclinic,P21,a=9.260(2),b=41.655(7),c=7.926(2) Å, β=97.996(13)°,R=9.4%. Structural properties of the title compounds are compared with those of 5-(5-chlorothien-2-yl)-2′-deoxyuridine (IV) previously reported in order to explain their affinity for HSV-1 thymidine kinase and their eventual interaction with viral DNA polymerase. The main structural features observed are the coplanarity of the uracil and thienyl cycles stabilized by a S−O intramolecular interaction and the formation of dimeric intermolecular H bonds between two uracil moieties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Prusoff, W.H.Biochem. Biophys. Acta 1959,32, 259.

    Google Scholar 

  2. Elion, B.G.; Furman, P.A.; Fyfe, F.A.; De Miranda, P.; Beauchamp, L.; Schaffer, H.J.Proc. Natl. Acad. Sci. USA 1977,74, 5716.

    Google Scholar 

  3. De Clercq, E.; Descamps, J.; De Somer, P.; Barr, P.J.; Jones, A.; Walker, R.T.Proc. Natl. Acad. Sci USA 1979,76, 2947.

    Google Scholar 

  4. Ruth, J.L.; Cheng, Y.-C.Mol. Pharmacol. 1981,20, 415.

    Google Scholar 

  5. Wigerinck, P.; Pannecouque, C.; Snoeck, T.; Claes, P.; De Clercq, E.; Herdewijn, P.J. Med. Chem. 1991,34, 2383.

    Google Scholar 

  6. Wigerinck, P.; Snoeck, R.; Claes, P.; De Clercq, E.; Herdewijn, P.J. Med. Chem. 1991,34, 1767.

    Google Scholar 

  7. Wigerinck, P.; Kerremans, L.; Claes, P.; Snoeck, R.; Maudgal, P.; De Clercq, E.; Herdewijn, P.J. Med. Chem. 1993,31, 538.

    Google Scholar 

  8. Olivier, A.; Creuven, I.; Evrard, C.; Evrard, G.; Dory, M.; Van Aerschot, A.; Wigerinck, P.; Herdewijn, P.; Durant, F.Antiviral Res. 1994,24, 289.

    Google Scholar 

  9. Sheldrick, G.M.SHELX86. Program for the solution of crystal structures; Institut für Anorganische Chemie der Universität Göttingen, Federal Republic of Germany, 1986.

    Google Scholar 

  10. Sheldrick, G.M.SHELXL93 Program for crystal structure determination; Institut fuer Anorg. Chemie: Univ. of Göttingen, Germany, 1993.

    Google Scholar 

  11. Platon92, Spek A.L.Acta Crystallogr. Sect. A 1990,46, C 31.

    Google Scholar 

  12. Johnson, C.J.ORTEP. report ORNL-3794; Oak Ridge National Laboratory, TN, 1965.

    Google Scholar 

  13. Lozac'h, N.Adv. Heterocycl. Chem. 1971,13, 161.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Creuven, I., Norberg, B., Olivier, A. et al. 5-(thien-2-yl) uracil analogs: 5-(5-methylthien-2-yl)-2′-deoxyuridine, 5-(5-thien-2-yl)-2′-deoxyuridine, and 5-(5-bromothien-2-yl)-2′-deoxyuridine. J Chem Crystallogr 26, 777–789 (1996). https://doi.org/10.1007/BF01664656

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01664656

Key Words

Navigation